| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |